Get the app
US › Healthcare

Scilex Holding Company (SCLX)

US · Healthcare · Drug Manufacturers - General

$2.83+0.35%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$7.6M
Revenue YoY
-22.8%
Net profit
$-113.5M
EPS
$-16.65
Net margin
-1,485.2%

Key statistics

Market cap
$20.0M
Forward P/E
5.6
P/B
28.85
Book value
$-43.83
EPS (TTM)
$-49.70
52-week high
$16.81
52-week low
$2.62
50-day MA
$5.24
200-day MA
$5.68
Beta
1.79

Analyst view

with an average price target of $490.00.

Shareholding

Insiders
11.67%
Institutions
8.51%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC4.28%
BlackRock Inc1.56%
Vanguard Fiduciary Trust Co0.65%
Jacobs Levy Equity Management, Inc.0.59%
State Street Corp0.50%
UBS Group AG0.47%
Renaissance Technologies Corp0.47%
Citadel Advisors Llc0.39%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scilex Holding Company — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-19.